Malcolm Salter

Malcolm Salter

Director/Board Member at
NextRNA Therapeutics, Inc.
86 year
Consumer Services
Commercial Services
Health Technology

Profile

Malcolm S.
Salter
is currently a Director at Raqia Therapeutics, Inc., NextRNA Therapeutics, Inc., AI Proteins, Inc., and Principal at Harvard Business School.
He previously served as an Independent Director at C4 Therapeutics, Inc. from 2015 to 2024 and as President at Mars & Co. Consulting, Inc. from 1986 to 2006.
He also held a position as a Trustee at Dana-Farber Cancer Institute, Inc. Mr. Salter obtained his undergraduate and doctorate degrees from Harvard University and an MBA from Harvard Business School.

Malcolm Salter active positions

CompaniesPositionStart
Corporate Officer/Principal -
Director/Board Member 2020-08-31
Director/Board Member 2021-01-31
Director/Board Member 2021-12-31

Former positions of Malcolm Salter

CompaniesPositionEnd
C4 THERAPEUTICS, INC. Director/Board Member 2024-08-28
President 2005-12-31
Director/Board Member -
See the detail of Malcolm Salter's experience

Training of Malcolm Salter

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

50

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Consumer Services

Health Services

Commercial Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Technology Services

  1. Stock Market
  2. Insiders
  3. Malcolm Salter